Assessment of the role of cannabinoid receptor 2 in innate immune cell trafficking during acute inflammation

<p>Activation of the cannabinoid receptor CB<sub>2</sub> has been shown to induce directed leukocyte migration and inhibit leukocyte chemotaxis towards CC chemokines. However, the role that CB<sub>2</sub> plays in regulating macrophage chemotaxis remains understudied. U...

Полное описание

Библиографические подробности
Главный автор: Taylor, L
Другие авторы: Greaves, D
Формат: Диссертация
Язык:English
Опубликовано: 2016
Предметы:
_version_ 1826302484630470656
author Taylor, L
author2 Greaves, D
author_facet Greaves, D
Taylor, L
author_sort Taylor, L
collection OXFORD
description <p>Activation of the cannabinoid receptor CB<sub>2</sub> has been shown to induce directed leukocyte migration and inhibit leukocyte chemotaxis towards CC chemokines. However, the role that CB<sub>2</sub> plays in regulating macrophage chemotaxis remains understudied. Using a real-time chemotaxis assay and a panel of chemically diverse CB<sub>2</sub> agonists, I set out to examine whether CB<sub>2</sub> modulates primary macrophage chemotaxis. Of 14 agonists tested, only a subset acted as <em>bona fide</em> macrophage chemoattractants. Surprisingly, despite being pertussis toxin-sensitive, neither pharmacological inhibition nor genetic ablation of CB<sub>2</sub> had any effect on CB<sub>2</sub> agonist-induced macrophage chemotaxis. Furthermore, the activation of CB2 had no effect on CCL2 or CCL5- induced macrophage chemotaxis. Therefore, the activation of CB2 does not inhibit CC chemokine-induced macrophage migration and a non-CB<sub>1</sub>/CB<sub>2</sub>, G<sub>i/o</sub>-coupled GPCR must transduce CB2 agonist-induced macrophage chemotaxis. To identify the GPCR responsible, I examined primary murine macrophage GPCR expression and found that they express 124 non-sensory GPCRs. Functional screening of candidate receptors demonstrated that the putative cannabinoid receptors GPR18 and GPR55 and the lipid binding GPCRs LPAR1&amp;5, CYSLTR1&amp;2 and GPER1, were not responsible for CB<sub>2</sub> agonist-induced macrophage chemotaxis. Alongside, a ligand-directed virtual screen, combined with functional testing, uncovered a novel chemotaxis positive chemical scaffold. Importantly, compounds in this series containing a photoaffinity label retained activity and will aid in the identification of the target(s) responsible for CB<sub>2</sub> agonist-induced macrophage chemotaxis in future photocrosslinking experiments. Finally, I assessed whether CB2 controls innate immune cell recruitment <em>in vivo</em> using the zymosan-induced dorsal air pouch inflammation model and animals genetically deleted for CB<sub>2</sub>. I found that CB<sub>2</sub><sup>-/-</sup> mice had increased air pouch neutrophil and monocyte numbers, as well as pro-inflammatory mediators, during the acute inflammatory phase. Interestingly, mixed bone marrow chimera experiments demonstrated that lack of CB<sub>2</sub> specifically in the myeloid population is responsible for increased neutrophil trafficking. Therefore these data demonstrate that CB<sub>2</sub> acts to regulate neutrophil recruitment during the acute inflammatory response.</p>
first_indexed 2024-03-07T05:48:15Z
format Thesis
id oxford-uuid:e7f3c9de-8418-480e-af09-317c91f796fd
institution University of Oxford
language English
last_indexed 2024-03-07T05:48:15Z
publishDate 2016
record_format dspace
spelling oxford-uuid:e7f3c9de-8418-480e-af09-317c91f796fd2022-03-27T10:42:54ZAssessment of the role of cannabinoid receptor 2 in innate immune cell trafficking during acute inflammationThesishttp://purl.org/coar/resource_type/c_db06uuid:e7f3c9de-8418-480e-af09-317c91f796fdImmunologyInflammationEnglishORA Deposit2016Taylor, LGreaves, D<p>Activation of the cannabinoid receptor CB<sub>2</sub> has been shown to induce directed leukocyte migration and inhibit leukocyte chemotaxis towards CC chemokines. However, the role that CB<sub>2</sub> plays in regulating macrophage chemotaxis remains understudied. Using a real-time chemotaxis assay and a panel of chemically diverse CB<sub>2</sub> agonists, I set out to examine whether CB<sub>2</sub> modulates primary macrophage chemotaxis. Of 14 agonists tested, only a subset acted as <em>bona fide</em> macrophage chemoattractants. Surprisingly, despite being pertussis toxin-sensitive, neither pharmacological inhibition nor genetic ablation of CB<sub>2</sub> had any effect on CB<sub>2</sub> agonist-induced macrophage chemotaxis. Furthermore, the activation of CB2 had no effect on CCL2 or CCL5- induced macrophage chemotaxis. Therefore, the activation of CB2 does not inhibit CC chemokine-induced macrophage migration and a non-CB<sub>1</sub>/CB<sub>2</sub>, G<sub>i/o</sub>-coupled GPCR must transduce CB2 agonist-induced macrophage chemotaxis. To identify the GPCR responsible, I examined primary murine macrophage GPCR expression and found that they express 124 non-sensory GPCRs. Functional screening of candidate receptors demonstrated that the putative cannabinoid receptors GPR18 and GPR55 and the lipid binding GPCRs LPAR1&amp;5, CYSLTR1&amp;2 and GPER1, were not responsible for CB<sub>2</sub> agonist-induced macrophage chemotaxis. Alongside, a ligand-directed virtual screen, combined with functional testing, uncovered a novel chemotaxis positive chemical scaffold. Importantly, compounds in this series containing a photoaffinity label retained activity and will aid in the identification of the target(s) responsible for CB<sub>2</sub> agonist-induced macrophage chemotaxis in future photocrosslinking experiments. Finally, I assessed whether CB2 controls innate immune cell recruitment <em>in vivo</em> using the zymosan-induced dorsal air pouch inflammation model and animals genetically deleted for CB<sub>2</sub>. I found that CB<sub>2</sub><sup>-/-</sup> mice had increased air pouch neutrophil and monocyte numbers, as well as pro-inflammatory mediators, during the acute inflammatory phase. Interestingly, mixed bone marrow chimera experiments demonstrated that lack of CB<sub>2</sub> specifically in the myeloid population is responsible for increased neutrophil trafficking. Therefore these data demonstrate that CB<sub>2</sub> acts to regulate neutrophil recruitment during the acute inflammatory response.</p>
spellingShingle Immunology
Inflammation
Taylor, L
Assessment of the role of cannabinoid receptor 2 in innate immune cell trafficking during acute inflammation
title Assessment of the role of cannabinoid receptor 2 in innate immune cell trafficking during acute inflammation
title_full Assessment of the role of cannabinoid receptor 2 in innate immune cell trafficking during acute inflammation
title_fullStr Assessment of the role of cannabinoid receptor 2 in innate immune cell trafficking during acute inflammation
title_full_unstemmed Assessment of the role of cannabinoid receptor 2 in innate immune cell trafficking during acute inflammation
title_short Assessment of the role of cannabinoid receptor 2 in innate immune cell trafficking during acute inflammation
title_sort assessment of the role of cannabinoid receptor 2 in innate immune cell trafficking during acute inflammation
topic Immunology
Inflammation
work_keys_str_mv AT taylorl assessmentoftheroleofcannabinoidreceptor2ininnateimmunecelltraffickingduringacuteinflammation